Susquehanna International Group’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-36,461
Closed -$2.73M 10589
2015
Q3
$2.73M Sell
36,461
-209,990
-85% -$15.7M ﹤0.01% 3669
2015
Q2
$18.6M Buy
246,451
+178,006
+260% +$9.54M 0.01% 1369
2015
Q1
$3.43M Buy
68,445
+49,552
+262% +$2.08M ﹤0.01% 3311
2014
Q4
$655K Buy
18,893
+9,700
+106% +$338K ﹤0.01% 6696
2014
Q3
$301K Sell
9,193
-15,028
-62% -$529K ﹤0.01% 8027
2014
Q2
$929K Buy
24,221
+15,660
+183% +$547K ﹤0.01% 6203
2014
Q1
$340K Buy
8,561
+2,319
+37% +$104K ﹤0.01% 7407
2013
Q4
$233K Sell
6,242
-4,841
-44% -$201K ﹤0.01% 8016
2013
Q3
$506K Buy
+11,083
New +$331K ﹤0.01% 6405

Susquehanna International Group's KYTH Position: Q4 2015 in Review

Susquehanna International Group sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 36,461 shares — an estimated $2.73M sold.

Susquehanna International Group first reported a position in KYTH in Q3 2013 and held it in 9 quarters. The position peaked at $18.6M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Susquehanna International Group reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Susquehanna International Group sold 36,461 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $2.73M.
  • Susquehanna International Group first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2013 and held it in 9 quarters.
  • Susquehanna International Group's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $18.6M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Susquehanna International Group's 13F filing for Q4 2015, filed 16 Feb 2016.